ESR1 and breast cancer: However, our previous analysis in the Netherlands Cohort Study [3] and a Danish study using acrylamide hemoglobin adducts as a marker of internal acrylamide exposure [4] gave some indications for a positive association between acrylamide intake and estrogen receptor-positive (ER+) breast cancer risk.